SUPRIYA

Supriya Lifescience Share PriceSupriya Lifescience

₹187.15
0.15 (0.08%)
As on 22 March, 2023 | 02:36 BSE: 543434 NSE: SUPRIYA

Supriya Lifescience Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Supriya Lifescience

Start SIP

Supriya Lifescience Share Price

  • Over 1 Month -10.26%
  • Over 3 Month -22.71%
  • Over 6 Month -45.02%
  • Over 1 Year -60.27%

Supriya Lifescience Key Statistics

P/E Ratio 15.4
PEG Ratio -0.4
Market Cap Cr 1,506
Price to Book Ratio 2.4
EPS 18.9
Dividend 0.3
Relative Strength Index 33.17
Money Flow Index 51.59
MACD Signal -3.66
Average True Range 8.22

Supriya Lifescience Investment Rating

  • Master Rating:
  • Supriya Lifescience has an operating revenue of Rs. 499.94 Cr. on a trailing 12-month basis. An annual revenue growth of 36% is outstanding, Pre-tax margin of 39% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 58 which is a POOR score indicating inconsistency in earnings, a RS Rating of 7 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 169 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Supriya Lifescience Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 105112101181
Operating Expenses Qtr Cr 916170106
Operating Profit Qtr Cr 14523175
Depreciation Qtr Cr 3333
Interest Qtr Cr 12411
Tax Qtr Cr 311529
Net Profit Qtr Cr 10172546

Supriya Lifescience Technicals

EMA & SMA

Current Price
₹187.15
0.15 (0.08%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 200.32
  • 50 Day
  • 211.09
  • 100 Day
  • 234.21
  • 200 Day
  • 283.58
  • 20 Day
  • 201.3
  • 50 Day
  • 209.68
  • 100 Day
  • 229.02
  • 200 Day
  • 284.79

Supriya Lifescience Resistance and Support

PIVOT
₹189.44
Resistance
First Resistance 192.87
Second Resistance 198.74
Third Resistance 202.17
RSI 33.17
MFI 51.59
MACD Single Line -3.66
MACD -4.98
Support
First Resistance 183.57
Second Resistance 180.14
Third Resistance 174.27

Supriya Lifescience Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 162,161 7,474,000 46.09
Week 191,009 9,120,680 47.75
1 Month 203,252 8,164,633 40.17
6 Month 244,615 10,197,988 41.69

Supriya Lifescience Result Highlights

Supriya Lifescience Synopsis

NSE-Medical-Supplies

Supriya Lifescience is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 530.05 Cr. and Equity Capital is Rs. 16.10 Cr. for the Year ended 31/03/2022. Supriya Lifescience Ltd. is a Public Limited Listed company incorporated on 26/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH2008PLC180452 and registration number is 180452.
Market Cap 1,506
Sales 500
Shares in Float 2.58
No of funds 22
Yield 0.32
Book Value 2.48
U/D Vol ratio 0.7
LTDebt / Equity
Alpha -0.32
Beta 1.24

Supriya Lifescience

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 68.24%68.24%68.24%
Mutual Funds 2.38%2.38%3.12%
Insurance Companies 3.85%3.85%4.15%
Foreign Portfolio Investors 6.24%6.79%5.99%
Individual Investors 15.07%13.4%12.52%
Others 4.22%5.34%5.98%

Supriya Lifescience Management

Name Designation
Mr. Satish Waman Wagh Chairman & Managing Director
Ms. Smita Satish Wagh Whole Time Director
Ms. Saloni Satish Wagh Whole Time Director
Ms. Shivani Satish Wagh Whole Time Director
Mr. Balasahab Gulabrao Sawant Whole Time Director
Mr. Kedar Shankar Karmarkar Independent Director
Mr. Bhairav Manojbhai Chokshi Independent Director
Mr. Dileep Kumar Jain Independent Director
Mr. Dinesh Navnitlal Modi Independent Director
Ms. Neelam Yashpal Arora Independent Director

Supriya Lifescience Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Supriya Lifescience MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 23910
Motilal Oswal S&P BSE Healthcare ETF 6

Supriya Lifescience FAQs

What is Share Price of Supriya Lifescience ?

Supriya Lifescience share price is ₹187 As on 22 March, 2023 | 02:22

What is the Market Cap of Supriya Lifescience ?

The Market Cap of Supriya Lifescience is ₹1506.2 Cr As on 22 March, 2023 | 02:22

What is the P/E ratio of Supriya Lifescience ?

The P/E ratio of Supriya Lifescience is 15.4 As on 22 March, 2023 | 02:22

What is the PB ratio of Supriya Lifescience ?

The PB ratio of Supriya Lifescience is 2.4 As on 22 March, 2023 | 02:22

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number